FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the pharmaceutical industry, specifically to the use of a depigmented polymerised extract of an allergen for the treatment of allergy. Depigmented polymerised extract of allergen selected from peanuts, ragwort pollen (Ambrosia artemisiifolia), timothy grass (Phleum pretense) and cat's epithelium, for treating allergy, where the extract is soluble in an aqueous medium and is characterized by the absence of unpolymerised allergens and proteins and polymerised molecules with molecular weight below 100 kDa. Using the depigmented polymerised allergen extract. Pharmaceutical composition for allergy treatment. Vaccine for treating allergy.
EFFECT: above-described group of inventions enables using the allergen of better quality for treating allergy.
10 cl, 9 dwg, 9 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING ALLERGEN EXTRACT | 2011 |
|
RU2572230C2 |
METHODS OF CLEANING ALLERGEN EXTRACT | 2019 |
|
RU2809823C2 |
NEW ALLERGEN | 2011 |
|
RU2608494C2 |
ALLERGEN-CONTAINING DOSAGE FORM | 2003 |
|
RU2372074C2 |
ALLERGENS PRODUCED BY RECOMBINANT METHODS | 2010 |
|
RU2592674C2 |
HUMAN ANTIBODIES TO Fel d1 AND METHODS OF USE THEREOF | 2013 |
|
RU2658491C2 |
METHOD FOR ISOLATING AND PURIFYING ALLERGENS FROM HERBAL POLLEN | 2000 |
|
RU2242248C2 |
HYBRID PEPTIDE CARRYING PROTEINS AS VACCINES AGAINST ALLERGY | 2012 |
|
RU2630652C2 |
VETERINARY PRODUCT | 2018 |
|
RU2819906C2 |
NEW PROSTATE KALLIKREIN ALLERGEN | 2007 |
|
RU2502074C2 |
Authors
Dates
2019-11-20—Published
2011-02-11—Filed